abstract |
The present invention relates to a method for inhibiting Serpinc1 expression using an iRNA such as a double-stranded ribonucleic acid (dsRNA), a composition targeting the Serpincl gene, and an iRNA such as a dsRNA, composition, and hemophilia And a method of treating a subject having a bleeding disorder such as. |